RU2003108464A - METHOD FOR PHARMACOLOGICAL CORRECTION OF ENDOGENOUS INTOXICATION IN ACUTE DESTRUCTIVE PANCREATITIS - Google Patents

METHOD FOR PHARMACOLOGICAL CORRECTION OF ENDOGENOUS INTOXICATION IN ACUTE DESTRUCTIVE PANCREATITIS

Info

Publication number
RU2003108464A
RU2003108464A RU2003108464/14A RU2003108464A RU2003108464A RU 2003108464 A RU2003108464 A RU 2003108464A RU 2003108464/14 A RU2003108464/14 A RU 2003108464/14A RU 2003108464 A RU2003108464 A RU 2003108464A RU 2003108464 A RU2003108464 A RU 2003108464A
Authority
RU
Russia
Prior art keywords
destructive pancreatitis
acute destructive
endogenous intoxication
pharmacological correction
acute
Prior art date
Application number
RU2003108464/14A
Other languages
Russian (ru)
Other versions
RU2245718C2 (en
Inventor
Ольга Владимировна Горох
Татьяна Александровна Крайнова
Любовь Михайловна Ефремова
Александр Павлович Медведев
Татьяна Леонидовна Парунова
Дмитрий Николаевич Парунов
Татьяна Валерьевна Ваганова
Original Assignee
Нижегородское государственное предприятие по производству бактерийных препаратов фирма "ИмБио"
Filing date
Publication date
Application filed by Нижегородское государственное предприятие по производству бактерийных препаратов фирма "ИмБио" filed Critical Нижегородское государственное предприятие по производству бактерийных препаратов фирма "ИмБио"
Priority to RU2003108464/14A priority Critical patent/RU2245718C2/en
Priority claimed from RU2003108464/14A external-priority patent/RU2245718C2/en
Publication of RU2003108464A publication Critical patent/RU2003108464A/en
Application granted granted Critical
Publication of RU2245718C2 publication Critical patent/RU2245718C2/en

Links

Claims (1)

Способ фармакологической коррекции эндогенной интоксикации при остром деструктивном панкреатите, включающий базисную терапию, отличающийся тем, что в комплексном лечении острого деструктивного панкреатита вводят церулоплазмин в дозе 600-1000 мг/сутки в течение 5 дней, с возможными повторными курсами.A method for the pharmacological correction of endogenous intoxication in acute destructive pancreatitis, including basic therapy, characterized in that ceruloplasmin is administered in a dose of 600-1000 mg / day for 5 days in the complex treatment of acute destructive pancreatitis, with possible repeated courses.
RU2003108464/14A 2003-03-26 2003-03-26 Method for pharmacological correction of endogenous intoxication in case of acute destructive pancreatitis RU2245718C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003108464/14A RU2245718C2 (en) 2003-03-26 2003-03-26 Method for pharmacological correction of endogenous intoxication in case of acute destructive pancreatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003108464/14A RU2245718C2 (en) 2003-03-26 2003-03-26 Method for pharmacological correction of endogenous intoxication in case of acute destructive pancreatitis

Publications (2)

Publication Number Publication Date
RU2003108464A true RU2003108464A (en) 2004-09-27
RU2245718C2 RU2245718C2 (en) 2005-02-10

Family

ID=35208933

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003108464/14A RU2245718C2 (en) 2003-03-26 2003-03-26 Method for pharmacological correction of endogenous intoxication in case of acute destructive pancreatitis

Country Status (1)

Country Link
RU (1) RU2245718C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2525670C1 (en) * 2013-06-04 2014-08-20 Тимур Назирович Хафизов Method of endovascular prevention of endotoxinemia in laparoscopic interventions in patients with acute abdominal pathology, complicated with peritonitis

Similar Documents

Publication Publication Date Title
NO2020007I1 (en) Sitagliptin, optionally in the form of a pharmaceutically acceptable salt
NO2017047I1 (en) Tofacitinib, optionally in the form of a pharmaceutically acceptable salt, including citrate salt
ATE540690T1 (en) INSULIN COMBINATIONS
TR200002786T2 (en) A new galenic formulation for meloxicam.
WO2005096990A3 (en) Novel modification of medical prostheses
DE602006020070D1 (en) REDUCTION OF SWALLOWS, A SIDE EFFECTS RELATED TO PIRFENIDON THERAPY
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
TW200504078A (en) Therapeutically active compounds and their use
MXPA05013974A (en) Pharmaceutical formulations of amyloid inhibiting compounds.
DK1689404T3 (en) Combination of et-743 with 5-fluoracil prodrugs for the treatment of cancer
RU2003127718A (en) APPLICATION OF FLUMAZENIL IN THE PRODUCTION OF A MEDICINE FOR TREATING COCAIN DEPENDENCE
RU2003108464A (en) METHOD FOR PHARMACOLOGICAL CORRECTION OF ENDOGENOUS INTOXICATION IN ACUTE DESTRUCTIVE PANCREATITIS
WO2004080477A8 (en) Aplidine for multiple myeloma treatment
RU2002103808A (en) METHOD FOR TREATING PAIN SYNDROME IN ONCOLOGIC PATIENTS
FI20020197A0 (en) A combination treatment method for acute myocardial infarction
RU2006119263A (en) METHOD FOR TREATING PATIENTS WITH ROSATSEA
EE200200605A (en) Use of a Substituted Acryloyldistamycin Derivative in the manufacture of a medicament for the treatment of tumors associated with high levels of glutathione
EA200401454A1 (en) NEW COMBINATION FROM REVERSIBLE ACTING PROTONE PUMP INHIBITORS AND USED IN THE THERAPY OF RESPIRATORY WAYS OF MEDICINAL SUBSTANCES FOR THE TREATMENT OF RESPIRATORY DISEASES
JP2006505577A5 (en)
RU2005102282A (en) METHOD FOR TREATMENT OF ANXIETY-DEPRESSIVE DISORDERS AND VEGETATIVE IMBALANCE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
EP1827494A4 (en) Combination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs
RU2006137701A (en) COMBINED THERAPY WITH EPOTHYLON AND CARBOPLATIN
GB0229022D0 (en) Organic Compounds
RU2003118635A (en) METHOD FOR TREATING DIABETIC NEUROPATHY
RU2004136539A (en) METHOD FOR INTEGRATED TREATMENT OF Lymphogranulomatosis